The biology of oxygen

European Respiratory Journal

Volumn 31, Issue 4, 2008, Pages 887-890

  Wagner, P D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypoxia; Hypoxic gene expression; O2 toxicity; O2 transport; Tissue perfusion

Indexed keywords

HEMOGLOBIN; MYOGLOBIN; OXYGEN; VASCULOTROPIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CONFERENCE PAPER; EXERCISE; GENE EXPRESSION; GENOME; HUMAN; HYPOXIA; IN VIVO STUDY; INFLAMMATION; LUNG TOXICITY; MAMMAL CELL; NONHUMAN; OXYGEN SATURATION; OXYGEN TRANSPORT; OXYGENATION; PHENOTYPE; PRIORITY JOURNAL; TISSUE PERFUSION; ANIMAL; ENERGY METABOLISM; LUNG GAS EXCHANGE; MAMMAL; METABOLISM; PHYSIOLOGY; PLANT; REVIEW;

ANIMALS; ENERGY METABOLISM; HEMOGLOBINS; MAMMALS; MYOGLOBIN; OXYGEN; PLANTS; PULMONARY GAS EXCHANGE; REACTIVE OXYGEN SPECIES;

EID: 42949144160     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00155407     Document Type: Conference Paper

References (39)

1. Evans JW, Wagner PD. Limits on VA/Q distributions from analysis of experimental inert gas elimination. J Appl Physiol 1977; 42: 889-898.
2. Giaccia AJ, Simon MC, Johnson R. The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease. Genes Dev 2004; 18: 2183-2194.
3. Piiper J, Scheid P. Comparison of diffusion and perfusion limitations in alveolar gas exchange. Respir Physiol 1983; 51: 287-290.
4. Rahn H, Fenn WO, eds. A Graphical Analysis of the Respiratory Gas Exchange. Washington DC, American Physiological Society, 1955.
5. Riley RL, Cournand A. Analysis of factors affecting partial pressures of oxygen and carbon dioxide in gas and blood of lungs: theory. J Appl Physiol 1951; 4: 77-101.
6. West JB. Ventilation-perfusion inequality and overall gas exchange in computer models of the lung. Respir Physiol 1969; 7: 88-110.
7. West JB. Pulmonary Gas Exchange: Ventilation, Blood Flow and Diffusion. New York, Academic Press, 1980.
8. Wagner PD, Gale GE, Moon RE, Torre-Bueno JR, Stolp WB, Saltzman HA. Pulmonary gas exchange in humans exercising at sea level and simulated altitude. J Appl Physiol 1986; 61: 260-270.
9. Wagner PD, Sutton JR, Reeves JT, Cymerman A, Groves BM, Malconian MK. Operation Everest II: pulmonary gas exchange during a simulated ascent of Mt. Everest. J Appl Physiol 1987; 63: 2348-2359.
10. 2 transport. J Clin Invest 1995; 96: 1916-1926.
11. Wilson DF, Erecińska M, Drown C, Silver IA. Effect of oxygen tension on cellular energetics. Am J Physiol 1977; 233: C135-C140.
12. 2 delivery in dog muscle in situ. J Appl Physiol 1991; 70: 2656-2662.
13. 2 delivery in dog muscle in situ. J Appl Physiol 1998; 84: 995-1002.
14. 2max in normal humans. J Appl Physiol 1989; 67: 291-299.
15. Wagner PD. Determinants of maximal oxygen transport and utilization. Annu Rev Physiol 1996; 58: 21-50.
16. Wagner PD. Determinants of maximal oxygen transport and utilization. In: Massaro D, ed. Annual Reviews of Physiology. Palo Alto, CA,Annual Reviews, 1996; pp. 21-50.
17. Clifford PS, Hellsten Y. Vasodilatory mechanisms in contracting skeletal muscle. J Appl Physiol 2004; 97: 393-403.
18. Dinenno FA. Hypoxic regulation of blood flow in humans. Alpha-adrenergic receptors and functional sympatholysis in skeletal muscle. Adv Exp Med Biol 2003; 543: 237-248.
19. Halliwill JR. Hypoxic regulation of blood flow in humans. Skeletal muscle circulation and the role of epinephrine. Adv Exp Med Biol 2003; 543: 223-236.
20. Semenza GL, Shimoda LA, Prabhakar NR. Regulation of gene expression byHIF-1. Novartis Found Symp 2006; 272: 2-8.
21. Breen EC, Johnson EC, Wagner H, Tseng HM, Sung LA, Wagner PD. Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol 1996; 81: 355-361.
22. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845.
23. Hultgren H. High altitude pulmonary edema. In: Hultgren H, ed. High Altitude Medicine. Stanford, Hultgren Publications, 1997; pp. 256-320.
24. DeGraff AC Jr, Grover RF, Johnson RL Jr, Hammond JW Jr, Miller JM. Diffusing capacity of the lung in Caucasians native to 3,100 m. J Appl Physiol 1970; 29: 71-76.
25. Schoene RB, Roach RC, Lahiri S, Peters RM Jr, Hackett PH, Santolaya R. Increased diffusion capacity maintains arterial saturation during exercise in the Quechua Indians of Chilean altiplano. Am J Hum Biol 1990; 2: 663-668.
26. Wagner PD, Araoz M, Boushel R, et al. Pulmonary gas exchange and acid-base state at 5,260 m in high-altitude Bolivians and acclimatized lowlanders. J Appl Physiol 2002; 92: 1393-1400.
27. Messner R, Salkeld A, eds. Everest. Expedition to the Ultimate. London, Oxford University Press, 1979.
28. West JB, Lahiri S, Maret KH, Peters RM Jr, Pizzo CJ. Barometric pressures at extreme altitudes on Mt. Everest: physiological significance. J Appl Physiol 1983; 54: 1188-1194.
29. Sutton JR, Reeves JT, Wagner PD, et al. Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J Appl Physiol 1988; 64: 1309-1321.
30. Ward MP, Milledge JS, West JB, eds. High Altitude Medicine and Physiology. London, Chapman and Hall Ltd, 1995.
31. Prabhakar NR, Kumar GK. Oxidative stress in the systemic and cellular responses to intermittent hypoxia. Biol Chem 2004; 385: 217-221.
32. Hoffmann M, Bybee K, Accurso V, Somers VK. Sleep apnea and hypertension. Minerva Med 2004; 95: 281-290.
33. Sharabi Y, Dagan Y, Grossman E. Sleep apnea as a risk factor for hypertension. Curr Opin Nephrol Hypertens 2004; 13: 359-364.
34. Svatikova A, Wolk R, Gami AS, Pohanka M, Somers VK. Interactions between obstructive sleep apnea and the metabolic syndrome. Curr Diab Rep 2005; 5: 53-58.
35. Hirota K, Semenza GL. Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases. Biochem Biophys Res Commun 2005; 338: 610-616.
36. Lahiri S, Roy A, Baby SM, Hoshi T, Semenza GL, Prabhakar NR. Oxygen sensing in the body. Prog Biophys Mol Biol 2006; 91: 249-286.
37. Tang K, Breen EC, Gerber HP, Ferrara NMA, Wagner PD. Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. Physiol Genomics 2004; 18: 63-69.
38. Olfert IM, Howlett RA, Breen EC, Wagner PD. Reduced endurance exercise capacity following skeletal muscle targeted VEGF gene deletion in mice. FASEB J 2005; 19: A132.
39. Tang K, Rossiter HB, Wagner PD, Breen EC. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol 2004; 97: 1559-1566.